Suggestions
Kelly Price
US Head Of Rare Disease
Professional Background
Kelly Price is a seasoned professional who has cultivated a remarkable career in the healthcare and pharmaceutical sectors. With a strong foundation in nursing, she has transitioned through various leadership roles that highlight her extensive expertise in market access, patient advocacy, and rare disease management. Currently serving as the US Head of Rare Disease at HRA Pharma, Kelly is at the forefront of enhancing the lives of patients affected by rare conditions, ensuring they have access to vital therapeutic options.
Throughout her career, Kelly has demonstrated a keen ability to strategize and implement policies that improve patient access to medications and healthcare services. Her role as Vice President of Market Access at Mahana Therapeutics further showcases her capacity for innovative thinking in the realm of digital therapeutics, where she worked to ensure that cutting-edge solutions reached those who need them most. Her extensive experience in patient access makes her a sought-after expert in the pharmaceutical industry.
Previously, as Vice President of Patient and Market Access at Osmotica Pharmaceutical Corp., Kelly played a crucial role in the company’s market strategies, effectively navigating the complexities of healthcare insurance to facilitate wider patient access to vital medications. She also served as President of Direct Success, Inc., where her leadership drove the company’s mission to improve patient outcomes through engaging programs and services that prioritize patient needs.
Her career began to take shape at Medimetriks Pharmaceuticals, Inc., where she functioned as the Director of Market Access and Pharmacy. In this capacity, Kelly honed her skills in developing effective market strategies to enhance patient engagement and accessibility to pharmaceutical products. Earlier in her career, she served as Chief Operating Officer at Advanced Script Specialty Pharmacy, significantly contributing to the operational excellence and strategic direction of the pharmacy.
Kelly's beginnings in the industry were marked by her role as an Immunology Sales Specialist at UCB, where she gained hands-on experience in navigating the complexities of patient needs and pharmaceutical solutions, further igniting her passion for patient advocacy and healthcare access.
Education and Achievements
Kelly Price pursued her higher education at Baylor University, earning a Bachelor of Science in Nursing with a focus on Registered Nursing. This educational background not only provided her with the knowledge and skills necessary for nursing practice but also laid the groundwork for her successful career in the healthcare and pharmaceutical industries.
With her deep understanding of the healthcare landscape, Kelly has become a prominent figure in organizations aimed at improving patient access and care. Her educational credentials, combined with her professional experiences, have positioned her as a trusted leader in market access strategies, particularly within the context of rare disease treatment.
With numerous leadership roles behind her, she has amassed a wealth of knowledge that allows her to address the needs of patients and healthcare providers alike. Under her guidance, project teams have been able to adapt and thrive in changing environments, ensuring that patient care remains at the center of healthcare strategies.
Kelly’s commitment to the healthcare community extends beyond her professional responsibilities, as she actively seeks opportunities to mentor emerging professionals in the field. Her dedication to fostering the development of others reflects her belief in the importance of strong leadership in navigating the complexities of healthcare systems.
Achievements
- US Head of Rare Disease at HRA Pharma: Kelly leads initiatives aimed at ensuring accessibility to treatments for patients with rare diseases, focusing on patient-centered strategies and policy development.
- VP Market Access at Mahana Therapeutics: Instrumental in integrating digital therapeutics into healthcare solutions while enhancing patient access to innovative treatments.
- Vice President, Patient and Market Access at Osmotica Pharmaceutical Corp: Drove market access strategies that increased patient engagement and improved access to essential medications.
- President at Direct Success, Inc: Spearheaded initiatives that prioritized patient outcomes and facilitated communication between healthcare entities and patients.
- Director of Market Access and Pharmacy at Medimetriks Pharmaceuticals, Inc: Developed strategic market plans that enhanced product accessibility for patients in various therapeutic areas.
- Chief Operating Officer at Advanced Script Specialty Pharmacy: Streamlined operations and led strategic initiatives to improve patient service and care delivery.
- Immunology Sales Specialist at UCB: Developed essential relationships within the hea
